If a cancer drug clinical trial does not prove to be effective, then it's better to stop the trial. Drug companies invest a lot in research so they must make sure that it's really effective or they end up losing a lot of money.
|
Replied on Tuesday, February 8, 2011 3:43 AM
|
|